Future biotherapeutics have the potential to reach the clinic faster than ever before. In this webinar, Berkeley Lights experts present a unique integrated platform that accelerates both the identification of promising candidates and the production of leading therapeutic molecules. The platform leverages a new antibody discovery workflow capable of finding rare antibodies against difficult targets by screening up to 100,000 cells in less than a week. Once a therapeutic candidate is found, the platform then streamlines the path to the clinic via an expanding suite of superior cell line development capabilities.
Topics to be covered
Anupam Singhal, PhD
Senior Product Manager, Antibody Discovery
Director, Cell Line Development Product Management